AIMS Institute offers Galleri cancer screening blood test

AIMS Institute offers Galleri cancer screening blood testGet Ahead of Cancer When it’s Most Treatable

 

What is the importance of early detection?

  • Finding cancer early creates the best chance for successful treatment.
  • Today, there are 5 recommended cancer screening tests that together only account for 1 in 4 diagnosed cancers in patients over 50 years of age.
  • When cancers are diagnosed early before they have had a chance to spread, the overall 5-year survival rate is 4x higher than when diagnosed in later stages.

 

What is the Galleri Multi-Cancer Early Detection test?

  • The Galleri test screens for a signal shared by multiple cancers, many without recommended screening.
  • If a cancer signal is detected, the results predict where in the body the cancer is coming from to help guide your next steps.

 

Watch this video to learn more about how the Galleri test works:

https://youtu.be/ZqkuKb9yqVA?feature=shared

 

Who can benefit from the Galleri test?

  • The Galleri test is recommended for use in adults with an elevated risk for cancer, such as those aged 50 or older.
  • It is intended to be used in addition to and not replace other cancer screening tests your healthcare provider recommends.

 

Listen to Roger’s Galleri story about his early pancreatic cancer diagnosis: https://youtu.be/nOAgCqOu6NY?feature=shared

 

It is important to know that:

  • The Galleri test does not detect all cancers and not all cancers can be detected in the blood. False positive and false negative results do occur.
  • It should be used in addition to guideline-recommended cancer screenings such as mammography, colonoscopy, PSA, or cervical cancer screening.

 

AIMS Institute is proud to offer the Galleri® multi-cancer early detection test.

Our practice has a discounted price of $849 ($949 list price). Flexible payment options, such as 0% interest up to 12 months are also available. You may be able to use FSA or HSA funds to cover the cost of the test. The Galleri test is not covered by most health insurance plans.

 

Call us today at (206) 420-1321 and let us know if you want to take the Galleri test so we can be sure to have a kit reserved for you!

Latest Blog Posts

Envisioning Drug Peace in the Entheogenic Reformation:

Envisioning Drug Peace in the Entheogenic Reformation:

Incorporating the Spiritual Geography of Psychoactives in Post-Prohibition Public Health  Greetings, I am Sunil Aggarwal, a doctor and medical geographer and a member of the Sacred Garden Community. I hail from Oklahoma, a child of Indian Immigrants, and I live today in Seattle, which rests on the unceded territory of the co-Salish Duwamish People, and I am so honored to join you here in Portland, a city which rests on the traditional village sites of the Multnomah, Wasco, Cowlitz, Kathlamet, Clackamas, Bands of Chinook, Tualatin, Kalapuya, Molalla, and many others who made their homes along the Columbia River. The title ...

Read More
The Healing Mind: Integrating Mental Health into Cancer Care

The Healing Mind: Integrating Mental Health into Cancer Care

By: Atara Jaffe, ND Feelings of anxiety and depression are common and often overlooked aspects of an individual’s experience in the cancer care process. At AIMS Institute, we provide integrative mental health care through a variety of modalities to approach body and mind. Our oncology team members that have proficiency in mental health include: Dr. Atara Jaffe, ND, Dr. Ksenia Malarkey, ND, Dr. Raushanah Najeeullah, ND, Dr. Monet Anthony, ND, Dr. Leanna Standish, ND, PhD. Our other team members also have experience and background with mental health services including: Dr. Emily Whinkin, ND, MS, Dr. Sunil Aggarwal, MD, PhD, Dr. ...

Read More
Impacts to Anxiety, Depression, and Psycho-Spiritual Metrics after Ketamine-Assisted Psychotherapy in Palliative Care Patients at the AIMS Institute

Impacts to Anxiety, Depression, and Psycho-Spiritual Metrics after Ketamine-Assisted Psychotherapy in Palliative Care Patients at the AIMS Institute

Author: Thomas Luedeke, Seattle University https://scholarworks.seattleu.edu/dnp-projects/95/ Date of Award 2024 Document Type Project College/School College of Nursing Degree Name Doctor of Nursing Practice (DNP) Project Mentor Therry Rose Eparwa Readers Conor Watters Abstract There is considerable evidence that palliative care patients disproportionately experience anxiety, depression, and existential distress related to their chronic illnesses. Additionally, conventional therapies tend to be less effective in the treatment of this patient population. As such, research is being conducted into novel therapies. One of the promising therapies currently under active investigation is ketamine-assisted psychotherapy (KAP) which involves a combination of the administration of the dissociative anesthetic ...

Read More
Call Us Text Us
Skip to content